4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0000950170-24-007477
Chief Executive Officer sold 5,696 shares at $18.41 ($104,851)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kirn David Chief Executive Officer | 2024-01-23 | Sale | −5,696 | $18.41 | $104,851 | 1,151,154 | D |
| Open-market sales · 5,696 sh · avg $18.41 · $104,851 | |||||||
Loading xslF345X05/ownership.xml…